Elsevier

Stem Cell Research

Volume 10, Issue 1, January 2013, Pages 95-102
Stem Cell Research

Mesenchymal stem cells can improve anal pressures after anal sphincter injury

https://doi.org/10.1016/j.scr.2012.10.002Get rights and content
Under an Elsevier user license
open archive

Abstract

Objective.

Fecal incontinence reduces the quality of life of many women but has no long-term cure. Research on mesenchymal stem cell (MSC)-based therapies has shown promising results. The primary aim of this study was to evaluate functional recovery after treatment with MSCs in two animal models of anal sphincter injury.

Methods.

Seventy virgin female rats received a sphincterotomy (SP) to model episiotomy, a pudendal nerve crush (PNC) to model the nerve injuries of childbirth, a sham SP, or a sham PNC. Anal sphincter pressures and electromyography (EMG) were recorded after injury but before treatment and 10 days after injury. Twenty-four hours after injury, each animal received either 0.2 ml saline or 2 million MSCs labelled with green fluorescing protein (GFP) suspended in 0.2 ml saline, either intravenously (IV) into the tail vein or intramuscularly (IM) into the anal sphincter.

Results.

MSCs delivered IV after SP resulted in a significant increase in resting anal sphincter pressure and peak pressure, as well as anal sphincter EMG amplitude and frequency 10 days after injury. MSCs delivered IM after SP resulted in a significant increase in resting anal sphincter pressure and anal sphincter EMG frequency but not amplitude. There was no improvement in anal sphincter pressure or EMG with in animals receiving MSCs after PNC. GFP-labelled cells were not found near the external anal sphincter in MSC-treated animals after SP.

Conclusion.

MSC treatment resulted in significant improvement in anal pressures after SP but not after PNC, suggesting that MSCs could be utilized to facilitate recovery after anal sphincter injury.

Highlights

► This manuscript tests in vivo outcomes in an animal model. ► The animal model has been validated. ► IV and IM injection of mesenchymal stem cells in the anal sphincter were studied. ► Fecal incontinence is a symptom that needs a focus of attention for new therapies.

Cited by (0)

Moderated Poster Presentation: 39th Annual Scientific Meeting of International Continence Society, September 29–October 3, 2009, San Francisco, CA.